PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33139635-0	2020	Empagliflozin Inhibits Basal and IL-1beta-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells.	empagliflozin	0-13	C-C motif chemokine ligand 2	Homo sapiens	51-56	
33139635-0	2020	Empagliflozin Inhibits Basal and IL-1beta-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells.	empagliflozin	0-13	C-C motif chemokine ligand 2	Homo sapiens	57-61	
33139635-6	2020	The co-administration of Empa inhibited IL-1beta-mediated MCP-1/CCL2 (0.2-fold, each) and ET-1 (0.2-fold, each) mRNA expression as early as 1 h after ligand stimulation and for at least 24 h in both HPTC lines, respectively.	empagliflozin	25-29	C-C motif chemokine ligand 2	Homo sapiens	58-63	
33139635-6	2020	The co-administration of Empa inhibited IL-1beta-mediated MCP-1/CCL2 (0.2-fold, each) and ET-1 (0.2-fold, each) mRNA expression as early as 1 h after ligand stimulation and for at least 24 h in both HPTC lines, respectively.	empagliflozin	25-29	C-C motif chemokine ligand 2	Homo sapiens	64-68	
33139635-7	2020	This inhibitory effect of Empa on basal and IL-1beta-mediated MCP-1/CCL2 and ET-1 mRNA expression was corroborated at the protein level.	empagliflozin	26-30	C-C motif chemokine ligand 2	Homo sapiens	62-67	
33139635-7	2020	This inhibitory effect of Empa on basal and IL-1beta-mediated MCP-1/CCL2 and ET-1 mRNA expression was corroborated at the protein level.	empagliflozin	26-30	C-C motif chemokine ligand 2	Homo sapiens	68-72	
32264868-8	2020	EMPA and DAPA (100 muM) significantly reduced SA-induced inflammation (IL1beta, TNFalpha, MCP1), oxidant stress (SOD2, TXN, HO1), but not apoptosis in MAC.	empagliflozin	0-4	C-C motif chemokine ligand 2	Homo sapiens	90-94	
34064989-2	2021	We recently presented first evidence for anti-inflammatory potential of empagliflozin (Empa) under normoglycemic conditions in human proximal tubular cells (HPTC) by demonstrating Empa-mediated inhibition of IL-1beta-induced MCP-1/CCL2 and ET-1 expression on the mRNA and protein level.	empagliflozin	72-85	C-C motif chemokine ligand 2	Homo sapiens	225-230	
34064989-2	2021	We recently presented first evidence for anti-inflammatory potential of empagliflozin (Empa) under normoglycemic conditions in human proximal tubular cells (HPTC) by demonstrating Empa-mediated inhibition of IL-1beta-induced MCP-1/CCL2 and ET-1 expression on the mRNA and protein level.	empagliflozin	72-85	C-C motif chemokine ligand 2	Homo sapiens	231-235	
34064989-2	2021	We recently presented first evidence for anti-inflammatory potential of empagliflozin (Empa) under normoglycemic conditions in human proximal tubular cells (HPTC) by demonstrating Empa-mediated inhibition of IL-1beta-induced MCP-1/CCL2 and ET-1 expression on the mRNA and protein level.	empagliflozin	180-184	C-C motif chemokine ligand 2	Homo sapiens	225-230